Mostrando 5 resultados de: 5
Filtros aplicados
Subtipo de publicación
Article(5)
Área temáticas
Enfermedades(3)
Problemas sociales y servicios a grupos(2)
Economía(1)
Fisiología humana(1)
Medicina forense; incidencia de enfermedades(1)
Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data
ArticleAbstract: Background Hypertension is considered the most important risk factor for cardiovascular diseases, buPalabras claves:Autores:Agapay D., Alhabib K.F., Aliberti A., Aoucheva N., Attaei M.W., Auger D., Avezum A.J., Azad A.K., Bahonar A., Casaccia G., Casanova A., Cherry H.M., Chin S.L., Choudhury T., Chow C.K., Dagenais G.R., Dayal L., Dehghan M., Dejesus J., Devanath A., DIaz R., Elsheikh W., Gupta R., Hall K., Haque R., Hari D., Hassan I., Heldman L., Hu W., Hussain F., Igumbor E.U., Islam S., Joseph P.G., Kandy N., Kaur M., Kay I., Keneth J., Keys J., Khan M.U., Khatib R., Kruger L., Kutty R., Lanas F.T., Lear S.A., Leong D.P., Lewis B.S., Lewis G., Lindeman J., Linetsky B., Mackie P., Maini Cuneo J.M., Mannan A., Marcilio C.S., Mattos A.C., Mckee M., McQueen M.J., Mente A., Milazzo E., Mohan V., Mushtaha M., Oguz A., Oliveira G.B.F., Orlandini A., O’Donnell M., Parvin S., PATRICIO LOPEZ -JARAMILLO, Poirier P., Rabbani K.A., Rahman O., Ramacham S., Ramasundarahettige C., Ramezani E., Rangarajan S., Reyes A., Rimac J., Rosengren A., Shahrook S., Shifaly F., Sintaha M., Smyth A., Solano R., Swallow J., Szuba A., Talukdar A.T., Teo K.K., Tongana T., Tooheen R.B., Toscanelli S., Trottier M., Trottier S., Turbide G., Wang X., Wong G.W.K., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M., Zaki A., Zhang B., Zhang M.Fuentes:googlescopusRationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial
ArticleAbstract: Background: Covert vascular disease of the brain manifests as infarcts, white matter hyperintensitiePalabras claves:Anticoagulant, Clinical trial, COGNITION, magnetic resonance imaging, prevention, silent infarctAutores:Avezum A.J., Berkowitz S.D., Bhatt D.L., Bosch J.J., Branch K.R.H., Casanova A., Connolly S.J., Cook-Bruns N., Dagenais G.R., DIaz R., Eikelboom J.W., Ertl G., Fox K.A.A., Ha J.W., Hart R.G., Keltai K., Keltai M., Kim J.H., Liang Y., Liu L., Lonn E.M., Maggioni A.P., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Piegas L.S., Pogosova N., Probstfield J.L., Rydén L.E., Sharma M., Smith E.E., Störk S., Tonkin A.M., Varigos J.D., Vinereanu D., Wong G., Yuan F., Yusuf S., Zhu J.Fuentes:googlescopusRivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline: The COMPASS MRI Substudy
ArticleAbstract: Background and Purpose: Covert brain infarcts are associated with cognitive decline. It is not knownPalabras claves:aspirin, COGNITION, infarction, rivaroxaban, white matterAutores:Avezum A.J., Berkowitz S.D., Bhatt D.L., Bosch J.J., Branch K.R.H., Casanova A., Connolly S.J., Dagenais G.R., DIaz R., Dyal L., Eikelboom J.W., Ertl G., Fox K.A.A., Hart R.G., Keltai K., Keltai M., Kim J.H., Liang Y., Liu L., Lonn E.M., Maggioni A.P., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Piegas L.S., Pogosova N., Probstfield J.L., Reeh K.W., Rydén L.E., Sharma M., Smith E.E., Störk S., Tonkin A.M., Varigos J.D., Vinereanu D., Yusuf S., Zhu J.Fuentes:googlescopusPractice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study
ArticleAbstract: Background: Stroke disproportionately affects people in low-income and middle-income countries. AlthPalabras claves:Autores:Agapay S., Avezum A.J., Bladin C.F., CACCAVO A., Carcamo D., Carvalho A., Carvalho J.J., Casanova A., Cedrolla C.M., Chin S.L., Correa Vila Nova D., Czlonkowska A., Damasceno A., Daniel Tettamanti, Dans A.M., Dehghan M., Dejesus J., Della Vedova B., Desmery P.M., Devanath A., DIaz R., Diener H.C., Dowlatshahi D., Duran R.G., ElSayed A., Ferraz de Almeida A.C., Friedrich M., Garrote M., Gates P., Gebara O., Gladstone D., Gupta R., Hall K., Hankey G.J., Herkes G., Hernandez M.E., Huerta M.F., Hussain F.A., Iqbal R., Islam S., Iversen H.K., Kabali C., Keys J., Kraemer T., Lanas F.T., Langhorne P., Liu L., MacLeod M.J., Magazi D., Málaga G., Mathur N., McQueen M.J., Minelli C., Minuzzo L., Molinos J., Mondo C.K., Mota D.M., Nilanont Y., Nofal P.G., O'Donnell M., Ogah O.S., Ogunniyi A., Oguz A., Oliveira D.C., Oliveira L., Ouriques Martins S.C., Oveisgharan S., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Peñaherrera E., Pereira M.P., Pogosova N., Prabhakaran D., Rangarajan S., Rao-Melacini P., Reis H., Ritt L.E., Rodriguez M.A., Rosengren A., Rumboldt Z., Ryglewicz D., SCHYGIEL P.O., Shuaib A., Silver F., Silvia Cáceres, Sobral Sousa A.C., Sposato L., Teal P., Teixeira M., Turner M., Valdez P., Varigos J.D., Wang X., Wasay M., Weimar C., Xavier D., Yan Duarte, Yusoff K., Yusuf S., Yusufali A.M., Zhang H., Zhang X.M., Zurru M.C.Fuentes:googlescopusThe effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study
ArticleAbstract: Background Physical activity has a protective effect against cardiovascular disease (CVD) in high-inPalabras claves:Autores:Anjana R.M., Avezum A.J., Casanova A., Chuangshi W., DIaz R., Gasevic D., Gupta R., Hu W., Huaxing L., Iqbal R., Kumar R., Lear S.A., Leong D.P., Mohammadifard N., Nair S., Oguz A., PATRICIO LOPEZ -JARAMILLO, Poirier P., Rangarajan S., Rosengren A., Seron P., Swaminathan S., Swidon H., Teo K.K., Wei L., Yang W., Yusuf S., Zatońska K.Fuentes:googlescopus